Form 4 holding
Director
Esperion Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 24,565
- Estimated value
- $30,583
- Report date
- 27 May 2021
- Price
- $1.24
- Ownership
- By Alta Bioequities, L.P.
Daniel Janney - Director at Esperion Therapeutics, Inc.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- ESPR on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Daniel Janney since 16 Aug 2025
Reported holdings for Daniel Janney in Esperion Therapeutics, Inc.
Form 4 holding
Director
Esperion Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 23,449
- Estimated value
- $29,194
- Report date
- 27 May 2021
- Price
- $1.24
- Ownership
- Direct
Transaction history for Daniel Janney in Esperion Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.